PEMAZYRE: The First FDA-Approved Treatment for Adults With Previously Treated, Unresectable, Locally Advanced or Metastatic Cholangiocarcinoma With an FGFR2 Fusion or Other Rearrangement as Detected by an FDA-Approved Test.
This program is not CME accredited.
